Unique ID issued by UMIN | UMIN000016859 |
---|---|
Receipt number | R000016113 |
Scientific Title | Prospective Study of Reduced Port Surgery Combined with Transvaginal Specimen Extraction for Colorectal Cancer Resection |
Date of disclosure of the study information | 2015/03/21 |
Last modified on | 2022/09/07 21:48:23 |
Prospective Study of Reduced Port Surgery Combined with Transvaginal Specimen Extraction for Colorectal Cancer Resection
Prospective Study of Reduced Port Surgery Combined with Transvaginal Specimen Extraction for Colorectal Cancer Resection
Prospective Study of Reduced Port Surgery Combined with Transvaginal Specimen Extraction for Colorectal Cancer Resection
Prospective Study of Reduced Port Surgery Combined with Transvaginal Specimen Extraction for Colorectal Cancer Resection
Japan |
Colorectal cancer
Gastrointestinal surgery |
Malignancy
NO
To evaluate the safety of Reduced Port Surgery combined with transvaginal specimen extraction for colorectal cancer resection in multicenter prospective study
Safety
Confirmatory
Pragmatic
Phase I,II
Safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Reduced Port Surgery Combined with Transvaginal Specimen Extraction for Colorectal Cancer Resection
20 | years-old | <= |
80 | years-old | >= |
Female
(1) colorectal cancer patients undergoing elective surgery
(2) histologically proven colorectal carcinoma
(3) tumor located in the sigmoid colon or rectosigmoid colon
(4) Stage 0-I, according to the TNM classification system
(5) age >= 20 and <= 80 years, no willing to bear children, previous childbirth with vaginal delivery
(6) without any gynecological comorbidities need to be treated
(7) vaginal examination shows no inadequate conditions for transvaginal specimen extraction such as stenosis of vagina
(8) no history of diseases which could cause pelvic adhesion such as pelvic peritonitis
(9) PS (ECOG) 0 or 1
(10) no history of gastrointestinal resection (except appendectomy)
(11) no history of chemotherapy or radiotherapy for other cancers
(12) no preoperative chemotherapy or radiotherapy
(13) with a good condition of important organs
1. WBC : >= 3,000/mm3
2. platelet >= 100,000/mm3
3. serum creatinine <= 1.5mg/dL
4. ALT/AST <= 5-times the upper limit of normal in facility criteria
(14) provided written informed consent
(1) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ
(2) with uncontrolled diabetes mellitus (including the case requiring insulin administration)
(3) with uncontrolled congestive heart disease, ischemic heart disease, hypertension or arhythmia
(4) severe mental disease
(5) not appropriate for the study at the physician's assessment
20
1st name | Ichiro |
Middle name | |
Last name | Takemasa |
Graduate School of Medicine, Osaka University
Department of Gastroenterological Surgery
565-0871
2-2 Yamadaoka, Suita, Osaka, Japan
06-6879-3251
itakemasa@gesurg.med.osaka-u.ac.jp
1st name | Atsushi |
Middle name | |
Last name | Hamabe |
Graduate School of Medicine, Osaka University
Department of Gastroenterological Surgery
565-0871
2-2 Yamadaoka, Suita, Osaka, Japan
06-6879-3251
ahamabe@gesurg.med.osaka-u.ac.jp
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University
National Cancer Center
Other
National Cancer Center Hospital East
Osaka Medical College, Department of General and Gastrocnterological Surgery
Shinko Hospital
Tonan Hospital
Nagaoka Chuo General Hospital
Osaka University, Graduate School of Medicine
2-2 Yamadaoka, Suita, Osaka
06-6210-8290
jim-chiken@hp.crc.med.osaka-u.ac.jp
NO
2015 | Year | 03 | Month | 21 | Day |
Unpublished
Completed
2014 | Year | 02 | Month | 20 | Day |
2014 | Year | 05 | Month | 12 | Day |
2014 | Year | 05 | Month | 12 | Day |
2022 | Year | 09 | Month | 07 | Day |
2015 | Year | 03 | Month | 21 | Day |
2022 | Year | 09 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016113